NasdaqGS - Delayed Quote USD

Insmed Incorporated (INSM)

65.71
-2.04
(-3.01%)
At close: May 13 at 4:00:02 PM EDT
66.98
+1.27
+(1.93%)
After hours: May 13 at 7:55:15 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
381,030
363,707
305,208
245,358
188,461
Cost of Revenue
89,563
85,742
65,573
55,126
44,152
Gross Profit
291,467
277,965
239,635
190,232
144,309
Operating Expense
1,150,472
1,064,535
920,564
668,355
512,069
Operating Income
-859,005
-786,570
-680,929
-478,123
-367,760
Net Non Operating Interest Income Expense
-85,440
-84,913
-81,694
-26,446
-40,473
Other Income Expense
-64,789
-38,582
15,611
24,418
-28,179
Pretax Income
-1,009,234
-910,065
-747,012
-480,151
-436,412
Tax Provision
4,030
3,707
2,555
1,383
-1,758
Net Income Common Stockholders
-1,013,264
-913,772
-749,567
-481,534
-434,654
Diluted NI Available to Com Stockholders
-1,013,264
-913,772
-749,567
-481,534
-434,654
Basic EPS
-5.93
--
-5.34
-3.91
-3.88
Diluted EPS
-5.93
--
-5.34
-3.91
-3.88
Basic Average Shares
172,144
--
140,433
123,035
112,111
Diluted Average Shares
172,144
--
140,433
123,035
112,111
Total Operating Income as Reported
-980,887
-878,252
-709,626
-457,321
-375,094
Total Expenses
1,240,035
1,150,277
986,137
723,481
556,221
Net Income from Continuing & Discontinued Operation
-1,013,264
-913,772
-749,567
-481,534
-434,654
Normalized Income
-961,084.50
-875,161
-763,322
-511,891
-409,905.10
Interest Income
1,475
2,229
1,882
--
--
Interest Expense
80,060
80,258
76,256
22,455
38,583
Net Interest Income
-85,440
-84,913
-81,694
-26,446
-40,473
EBIT
-929,174
-829,807
-670,756
-457,696
-397,829
EBITDA
-917,866
-818,794
-660,177
-447,365
-383,647
Reconciled Cost of Revenue
83,307
79,781
60,046
49,848
35,022
Reconciled Depreciation
11,308
11,013
10,579
10,331
14,182
Net Income from Continuing Operation Net Minority Interest
-1,013,264
-913,772
-749,567
-481,534
-434,654
Total Unusual Items Excluding Goodwill
-66,050
-38,611
13,755
30,357
-24,849
Total Unusual Items
-66,050
-38,611
13,755
30,357
-24,849
Normalized EBITDA
-851,816
-780,183
-673,932
-477,722
-358,798
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-13,870.50
0
0
0
-100.10
12/31/2021 - 6/1/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CYTK Cytokinetics, Incorporated
30.61
-4.73%
 
NUVL Nuvalent, Inc.
71.42
-3.00%
 
RVMD Revolution Medicines, Inc.
39.95
-4.61%
 
CRNX Crinetics Pharmaceuticals, Inc.
30.95
-7.11%
 
RYTM Rhythm Pharmaceuticals, Inc.
56.79
-3.69%
 
ARGX argenx SE
542.47
-3.29%
 
ALNY Alnylam Pharmaceuticals, Inc.
266.86
-1.23%
 
APLS Apellis Pharmaceuticals, Inc.
17.28
-1.37%
 
ACLX Arcellx, Inc.
58.25
-2.10%
 
PCVX Vaxcyte, Inc.
30.05
-4.87%